EdexLive Desk
Developed by Bharat Biotech
It was brought out in collaboration with Washington University in St Louis
It is now available on CoWIN app
The trials
Phase III trials for iNCOVACC have already been completed
3,100 participants were screened
Who can take it?
Everyone over 18 years can take it as a booster dose
It is a heterologous vaccine
Any side effects?
News reports say that there are no major side effects
Doctors confirm this fact